AT315856B - Verfahren zur herstellung von neuen 4-hydroxy-6-aryl-bzw.6-heteroarylpyrimidinen - Google Patents

Verfahren zur herstellung von neuen 4-hydroxy-6-aryl-bzw.6-heteroarylpyrimidinen

Info

Publication number
AT315856B
AT315856B AT00148/73A AT14873A AT315856B AT 315856 B AT315856 B AT 315856B AT 00148/73 A AT00148/73 A AT 00148/73A AT 14873 A AT14873 A AT 14873A AT 315856 B AT315856 B AT 315856B
Authority
AT
Austria
Prior art keywords
heteroarylpyrimidines
aryl
hydroxy
preparation
new
Prior art date
Application number
AT00148/73A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AT315856B publication Critical patent/AT315856B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT00148/73A 1970-10-05 1971-10-05 Verfahren zur herstellung von neuen 4-hydroxy-6-aryl-bzw.6-heteroarylpyrimidinen AT315856B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7821670A 1970-10-05 1970-10-05

Publications (1)

Publication Number Publication Date
AT315856B true AT315856B (de) 1974-05-15

Family

ID=22142671

Family Applications (4)

Application Number Title Priority Date Filing Date
AT605473A AT317229B (de) 1970-10-05 1971-10-05 Verfahren zur Herstellung von neuen 4-Hydroxy-6-aryl-bzw. 6-heteroarylpyrimidinen
AT00149/73A AT316563B (de) 1970-10-05 1971-10-05 Verfahren zur herstellung von neuen 4-amino-6-aryl-pyrimidinen und von deren saeureadditionssalzen
AT858071A AT314540B (de) 1970-10-05 1971-10-05 Verfahren zur Herstellung von neuen 4-Amino-6-aryl- bzw. 6-heteroaryl-pyrimidinen und von deren Salzen
AT00148/73A AT315856B (de) 1970-10-05 1971-10-05 Verfahren zur herstellung von neuen 4-hydroxy-6-aryl-bzw.6-heteroarylpyrimidinen

Family Applications Before (3)

Application Number Title Priority Date Filing Date
AT605473A AT317229B (de) 1970-10-05 1971-10-05 Verfahren zur Herstellung von neuen 4-Hydroxy-6-aryl-bzw. 6-heteroarylpyrimidinen
AT00149/73A AT316563B (de) 1970-10-05 1971-10-05 Verfahren zur herstellung von neuen 4-amino-6-aryl-pyrimidinen und von deren saeureadditionssalzen
AT858071A AT314540B (de) 1970-10-05 1971-10-05 Verfahren zur Herstellung von neuen 4-Amino-6-aryl- bzw. 6-heteroaryl-pyrimidinen und von deren Salzen

Country Status (16)

Country Link
US (1) US3707560A (de)
JP (2) JPS5648511B1 (de)
AT (4) AT317229B (de)
AU (1) AU465734B2 (de)
BE (1) BE773484A (de)
CA (1) CA988519A (de)
CH (4) CH542218A (de)
DE (2) DE2165962C2 (de)
DK (1) DK131858C (de)
ES (4) ES395676A1 (de)
FI (1) FI55502C (de)
FR (1) FR2110227B1 (de)
GB (2) GB1373535A (de)
NL (1) NL168511C (de)
SE (2) SE385885B (de)
ZA (1) ZA716615B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3895112A (en) * 1970-10-05 1975-07-15 Pfizer Arylpyrimidines in the relaxation of smooth muscle
US3908012A (en) * 1970-10-05 1975-09-23 Pfizer Arylpyrimidines-inhibitors of platelet aggregation and bronchodilators
US3859288A (en) * 1970-10-05 1975-01-07 Pfizer Arylpyrimidines - inhibitors of platelet aggregation and bronchodilators
US3835132A (en) * 1972-02-01 1974-09-10 Shell Oil Co Morpholino-piperazinyl pyrimidines
US3950525A (en) * 1973-06-19 1976-04-13 Pfizer Inc. Relaxation of smooth muscle in a mammal
DE2343419A1 (de) * 1973-08-29 1975-03-13 Gruenenthal Chemie Verfahren zur herstellung von pyrimidinderivaten
US4725600A (en) * 1984-07-13 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine compounds having activity as a cardiotonic anti-hypertensive cerebrovascular vasodilator and anti-platelet aggregation agent
JPH0625157B2 (ja) * 1988-01-29 1994-04-06 宇部興産株式会社 4―ヒドロキシピリミジン類の製造方法
US4935516A (en) * 1988-01-29 1990-06-19 Ube Industries, Ltd. Process for preparing 4-hydroxypyrimidine
DE3825647A1 (de) * 1988-07-28 1990-02-01 Geyer Gmbh & Co Christian Vorrichtung zur befestigung eines elektrischen schaltgeraetes
DE3905364A1 (de) * 1989-02-22 1990-08-23 Hoechst Ag Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool
JP2003505384A (ja) 1999-07-15 2003-02-12 ファーマコピーア,インコーポレーティッド ブラジキニンb1受容体アンタゴニスト
ATE366045T1 (de) * 2002-03-15 2007-07-15 Ciba Sc Holding Ag Verwendung von 4-aminopyrimidinen zur antimikrobiellen behandlung von oberflächen
ES2355472T3 (es) * 2002-05-22 2011-03-28 Amgen Inc. Derivados de aminopirimidina para su uso como ligandos del receptor vaniloide para el tratamiento del dolor.
WO2004085433A2 (en) * 2003-03-28 2004-10-07 Pharmacia & Upjohn Company Llc Positive allosteric modulators of the nicotinic acetylcholine receptor
US20060235036A1 (en) * 2005-04-15 2006-10-19 Doherty Elizabeth M Vanilloid receptor ligands and their use in treatments
JP2009164373A (ja) * 2008-01-08 2009-07-23 Toshiba Corp 半導体装置
MX2012008346A (es) * 2010-01-25 2012-11-12 Chdi Foundation Inc Determinados inhibidores de cinurenina-3-monooxigenasa, composiciones farmceuticas y metodos de uso de los mismos.
AU2012300246A1 (en) 2011-08-30 2014-03-06 Chdi Foundation, Inc. Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
SG2014012926A (en) 2011-08-30 2014-06-27 Chdi Foundation Inc Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
US10258621B2 (en) 2014-07-17 2019-04-16 Chdi Foundation, Inc. Methods and compositions for treating HIV-related disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3047462A (en) * 1959-03-06 1962-07-31 Lab Jacques Logeais Soc D Expl Quinazolone anti-inflammatory composition

Also Published As

Publication number Publication date
AT317229B (de) 1974-08-26
CA988519A (en) 1976-05-04
BE773484A (fr) 1972-04-05
FR2110227A1 (de) 1972-06-02
DK131858B (da) 1975-09-15
GB1373535A (en) 1974-11-13
FI55502B (fi) 1979-04-30
NL168511C (nl) 1982-04-16
ES420210A1 (es) 1976-06-01
DE2165962C2 (de) 1982-05-13
DE2165962A1 (de) 1972-08-31
DK131858C (da) 1976-02-16
FI55502C (fi) 1979-08-10
GB1373536A (en) 1974-11-13
US3707560A (en) 1972-12-26
FR2110227B1 (de) 1975-02-07
AT314540B (de) 1974-04-10
AT316563B (de) 1974-06-15
JPS5636468A (en) 1981-04-09
ES420209A1 (es) 1976-06-01
ZA716615B (en) 1972-06-28
CH542218A (fr) 1973-11-15
ES420211A1 (es) 1976-03-16
DE2149249B2 (de) 1974-11-07
SE7410488L (de) 1974-08-16
JPS5648511B1 (de) 1981-11-16
DE2149249A1 (de) 1972-04-13
CH554876A (fr) 1974-10-15
SE390304B (sv) 1976-12-13
ES395676A1 (es) 1974-10-16
DE2149249C3 (de) 1975-07-03
CH554346A (fr) 1974-09-30
AU3425971A (en) 1973-04-12
CH554875A (fr) 1974-10-15
NL7113670A (de) 1972-04-07
NL168511B (nl) 1981-11-16
SE385885B (sv) 1976-07-26
AU465734B2 (en) 1975-10-09
JPS578107B2 (de) 1982-02-15

Similar Documents

Publication Publication Date Title
AT303040B (de) Verfahren zur Herstellung von neuen Azidophenyl-1,4-dihydroppyridinen
AT315856B (de) Verfahren zur herstellung von neuen 4-hydroxy-6-aryl-bzw.6-heteroarylpyrimidinen
AT319948B (de) Verfahren zur Herstellung von neuen 2,4-Diamino-5-benzylpyrimidinen
AT304530B (de) Verfahren zur Herstellung von neuen substituierten Phenyl-2-pyrrolidinonen
AT306238B (de) Verfahren zur Herstellung von neuen 3-Formylcephalosporinsulfoxyden
AT312606B (de) Verfahren zur Herstellung von neuen 2,2-Diaryl-4-piperidinbutyramiden
AT304545B (de) Verfahren zur Herstellung von neuen Nitrofuryl-triazolo-pyrimidinen
AT306260B (de) Verfahren zur Herstellung von neuen 3-Amino-cardenoliden
CH553758A (de) Verfahren zur herstellung von azidosulfonylcarbanilaten.
ATA1046871A (de) Verfahren zur herstellung von neuen 1-aminoisochinolinen
CH545305A (de) Verfahren zur Herstellung von neuen 3-Guanidinoalkylthiophenen
CH555332A (de) Verfahren zur herstellung von neuen 1,3,3-trisubstituierten 3-azolylpropinen.
AT306259B (de) Verfahren zur Herstellung von neuen 3-Oxo-11β,18-epoxy-17α-R-17β-hydroxyöstra-4,9-dienen
AT299945B (de) Verfahren zur Herstellung von neuen Isoxazolyläthyl-tetrahydropyranolen
AT321271B (de) Verfahren zur Herstellung von neuen Phenylhydraziden
CH557793A (de) Verfahren zur herstellung von sebacinsaeurediestern.
AT305301B (de) Verfahren zur Herstellung von neuen 6-Chlorpyridaziniumverbindungen
AT299946B (de) Verfahren zur Herstellung von neuen 1,3-Benzodioxol-2-thionen
AT306252B (de) Verfahren zur Herstellung von neuen 2,3-Alkylidenrhamnopyranosiden
AT315149B (de) Verfahren zur Herstellung von neuen ω-Alkenylpropiolophenonen
AT305280B (de) Verfahren zur Herstellung von neuen v-Triazolen
AT312174B (de) Verfahren zur Herstellung von neuen 16-Methylen-9β,10α-steroidverbindungen
AT308137B (de) Verfahren zur Herstellung von neuen substituierten N-Carbonylsulfonamiden
AT312621B (de) Verfahren zur Herstellung von neuen 2-Alkylmercapto-5-phenyl-4H-3,5-dihydro-1,5-benzodiazepin-4-onen
CH555851A (de) Verfahren zur herstellung von thiocyanatobenzothiazolen.

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee